Cerebrospinal fluid camk2a levels at baseline predict long-term progression in multiple sclerosis

BACKGROUND: Multiple sclerosis (MS) remains a highly unpredictable disease. Many hope that fluid biomarkers may contribute to better stratification of disease, aiding the personalisation of treatment decisions, ultimately improving patient outcomes. OBJECTIVE: The objective of this study was to eval...

Descripción completa

Detalles Bibliográficos
Autores principales: Sohaei, Dorsa, Thebault, Simon, Avery, Lisa M., Batruch, Ihor, Lam, Brian, Xu, Wei, Saadeh, Rubah S., Scarisbrick, Isobel A., Diamandis, Eleftherios P., Prassas, Ioannis, Freedman, Mark S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10466840/
https://www.ncbi.nlm.nih.gov/pubmed/37644477
http://dx.doi.org/10.1186/s12014-023-09418-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10466840/
https://www.ncbi.nlm.nih.gov/pubmed/37644477
http://dx.doi.org/10.1186/s12014-023-09418-9

Ejemplares similares